Key facts
- This page summarizes Weis Holger's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jul 2026, 16:15.
Weis Holger - 23 Jul 2026 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)
- SEC form
- 4
- Accepted by SEC
- 27 Jul 2026, 16:15:14 UTC
- Prior SEC filing
- 02 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- Weis Holger
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Weis Holger filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 27 Jul 2026.
Change
- Previous filing in this sequence was filed on 02 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001846984
Primary reporting owner
Weis Holger
- Relationship
- CEO
- Address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE
- Signature
- Weis Holger
- Signature date
- 27 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TCRT
transaction
Common Stock
Award
- Transaction value
- Shares
- +4,568
- Change %
- +28%
- Price
- $1.92*
- Shares after
- 21,120
- Date
- 23 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares of common stock issued in lieu of net salary.